TD Cowen analyst Dan Brennan raised the firm’s price target on Agilent (A) to $170 from $162 and keeps a Buy rating on the shares. The firm noted organic growth was strong and broad based and ahead of consensus but EBIT margins missed limiting upside to earnings.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on A:
- Agilent price target raised to $180 from $170 at UBS
- Agilent’s Strong Organic Growth and Strategic Positioning Justify Buy Rating and Raised Price Target
- Agilent price target raised to $165 from $142 at Baird
- Agilent price target raised to $165 from $150 at BofA
- Agilent price target raised to $180 from $165 at JPMorgan